Currently under development, Stem Cell Center NeuroTimone (SCeNT) will encompass dedicated spaces, equipment and competencies to support work involving human induced pluripotent stem cells (hiPSCs).
The primary mission of SCeNT will be to develop and provide cell reprograming-based tools to advance the neuroscience field by fostering basic and translational research and engaging in training for scientists to use hiPSCs for their research goals.
To reach its mission, SCeNT will progressively develop an array of services available to all scientists in need of our expertise. This includes (non-exhaustive list): i) hiPSC production/characterization; ii) maintenance/storage of hiPSC lines; iii) differentiation for the production of hiPSC-derivatives (on demand); iv) genome editing on hiPSCs (CRISPR-Cas9-based).
In addition, SCeNT will also offer individualized training for the culture, differentiation, and reprogramming techniques specific to pluripotent human stem cells and will therefore be available for consultation on experimental design, and on developing projects. Along this line, SCeNT will also function as a multi-user shared research facility dedicated to supporting work involving hiPSCs.
More detailed information (services; conditions and modalities; costs; etc.) will become available as the platform develops. Meanwhile, you can contact Dr Emmanuel Nivet for more information regarding SCeNT or if you have any collaborative interests on hiPSCs.